Bibliographic Metrics at JACC: Cardiovascular Imaging An Opportunity for Audit and Reflection by Marwick, Thomas H. et al.
OJ A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 4 , N O . 9 , 2 0 1 1
© 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 1 . 0 7 . 0 0 1Bibliographic Metrics at JACC: Cardiovascular Imaging
An Opportunity for Audit and Reﬂection
Thomas H. Marwick, MBBS, PHD, Y. Chandrashekhar, MD, DM, Stephan Achenbach, MD,
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Leslee J. Shaw, PHD, William A. Zoghbi, MD, Jagat Narula, MD, PHDver the last 2 years, the Impact Factor of
iJACC has averaged 5.52, meaning that
original articles published in the Journal
are cited by other papers an average of at
least 5.5 times. This parameter is an imperfect
marker of the quality of a journal for a variety of
reasons. As the citation of topics is nonuniform,
comparisons between specialties are problematic
(1). Even within a given specialty, new journals
compete within varying levels of density of new
and established journals in their field. Further, ar-
ticles may be well or poorly cited depending on
whether they are published in a high-, medium-,
or low-impact journal (2). Nonetheless, while Im-
pact Factor is an oversimplified marker of quality
(3), the recent provision of a bibliographic metric
for the first time since the inception of iJACC is a
landmark that provides an opportunity for audit
and reflection.
The goal of iJACC is to provide a forum for
communication about the relevant advances in
imaging, particularly when this involves consider-
ation of merits of more than one modality. We
have sought to bring the international cardiovas-
cular imaging community together. Our data
show that we are truly a global journal and analy-
ses of the bibliographic data show that this has
been a source of considerable strength for us; 50%
of our submissions and 40% of acceptances have
been from outside the United States. Overseas
papers contributed significantly to citations; nearly
one-third of the highest cited papers were from
outside the United States. One-third of our elite
reviewers and one-fifth of our editorialists were
from overseas.
From the JACC: Cardiovascular Imaging Editorial Office, San Diego,
California.Bringing cutting edge, original science to publi-
cation has been at the core of our philosophy, and
bibliographic data analysis shows that we achieved
this in large measure. Original science papers
formed the bulk of our highest cited articles, only
1 of the top 25 cited papers was a review article.
Since reviews are commonly thought to be more
citable than original papers, and since original pa-
pers far outnumbered reviews, our impact results
suggest that we have been successful in attracting
top quality, original, research contributions from
authors around the world.
iJACC has made a substantial effort to maintain
a balance between the needs and proven roles of
different imaging modalities, and has a uniform
decision process for papers in all modalities. Al-
though we seek to provide a forum for publica-
tions involving all imaging modalities, inevitably
the distribution of papers has been somewhat un-
equal, reflecting the number of submissions from
modalities of different maturity. Of more than
1,600 submitted papers over the first 2 years, 25%
were primarily related to echocardiography, 20%
to magnetic resonance imaging (MRI), 15% to
computed tomography (CT), 10% to invasive im-
aging, and 20% to a miscellaneous group includ-
ing health services research and reviews. The re-
maining submissions were on nuclear cardiology
topics, leading to a relative paucity of published
papers in this field. Our initial concern that the
newer imaging fields, with more opportunities for
newer and novel discoveries might inadvertently
receive an easier passage than more established
modalities including echocardiography and nu-
clear imaging has not been realized. Acceptance
rates did not differ significantly when stratified by
modality, ranging between 10% (CT) to 20%
(MRI, nuclear cardiology, and health services re-
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1051search), with echocardiography and invasive imag-
ing being in between (15%). Overall, these accep-
tance rates are lower than most authors would
prefer and we are working actively to make sure
high quality papers get an optimum chance of ac-
ceptance. The primary modality in the highest-
cited papers was echocardiography (30%), fol-
lowed by CT (25%), coronary imaging (20%),
nuclear (15%), and MRI (10%). While iJACC at-
tracted a broadly diversified portfolio of high im-
pact articles representing the entire breadth of
cardiovascular imaging, the Editors will continue
to make considerable efforts to foster the growth
of every imaging modality.
The announcement of the Impact Factor also
provides an opportunity to better understand the
effectiveness of the review and editorial process.
Each paper has been reviewed and scored by 2
(and not infrequently 3) reviewers, the Associate
Editor, the Editor, and discussed extensively dur-
ing our weekly editorial meetings. In order to
evaluate this process, we sought to characterize
the nature of the acceptances and rejections, start-
ing in 2007 (for papers subsequently published in
2008), in order to have sufficient follow-up to ex-
amine their subsequent impact. For example, of
the earliest acceptances, the 2 reviewers and Edi-
tors reached a concordant decision in favor of
publication in 84% of these papers. The average
number of citations in these accepted papers was
18.1  18.6 (true-positives). Five papers were
cited fewer times than the average iJACC Impact
actor (false-positives), giving us a sensitivity of
0% for predicting papers likely to be highly val-
ed by the field. Among the earliest rejections in
he same period, the reviewers and Editors
eached a concordant decision in favor of rejection2011 Mar 17 [E-pub ahead of print].
2
2010;40:587–91.in score between accepted and rejected papers
were in the realms of priority and methodology.
More than two-thirds of these papers (68%) have
subsequently been published. Of these rejections,
48% were accepted by subspecialty imaging jour-
nals, 12% were published in general cardiology
journals, and 32% still remain unpublished; 2 pa-
pers were modified, resubmitted with an appeal
and eventually accepted by iJACC. The average
citation for the rejected papers was 2.8. Of the
first 25 rejected papers, only 2 were cited more
times than the average iJACC paper (false-nega-
ives), giving our review process a specificity of
1% (true-negatives) for identifying science that is
ess likely, on average, to move the field forward
ignificantly.
Impact Factor is often considered to be a sub-
ect of primary interest for the authors, because in
any countries, Impact Factor is an important
riterion for grant awards and academic promo-
ions (4). However, citations are also a post hoc
easure of editorial success in achieving the goal
f publishing novel, relevant, correct, and inter-
sting papers—and therefore relevant to the Jour-
al’s quality control process. Inherently, a paper
hat is subsequently cited is a marker of work that
s relevant and topical in its field, useful to other
esearchers and the development of the scientific
vidence base.
Rather than to simply employ it as a competi-
ive yard-stick, we firmly believe that the achieve-
ent of an Impact Factor should be viewed as an
pportunity for the editorial team to reflect on
ur review process, to recommit ourselves to at-
racting the most important advances and robust
vidence, and to thank our reviewers for their
assion and commitment—nothing else could jus-n 72% of these papers. The greatest differences tify the time and attention of our readers.R E F E R E N C E S
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